Document is current
Any future updates will be listed below
-
Authors
Walker, Kimberly K. https://orcid.org/0000-0002-2825-2694
Kasting, Monica L. https://orcid.org/0000-0002-9879-7235
Head, Katharine J. https://orcid.org/0000-0001-8946-1716
Sturm, Lynne https://orcid.org/0000-0003-4340-2360
Zimet, Gregory D. https://orcid.org/0000-0003-3835-937X
-
Funding
Funding for this research was provided by:
Division of Cancer Epidemiology and Genetics, National Cancer Institute (P30CA08270918S4)
- License Information
-
More Information
Article History
Accepted: 24 January 2023
First Online: 6 February 2023
Declarations
:
: GDZ has served as a consultant to Merck (regarding HPV vaccination) and external advisory board member for Moderna (regarding COVID-19 vaccination) and Pfizer (regarding meningococcal vaccination). He has also received investigator-initiated research funding from Merck, administered through Indiana University. MLK has received investigator-initiated research funding from Merck, administered through Purdue University. KJH has received investigator-initiated research funding from Merck, administered through Indiana University, and serves as an unpaid advisory member to the Indiana Immunization Coalition.
